Literature DB >> 19617904

Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II-III trial (T-cell depletion trial).

C A Keever-Taylor, J E Wagner, N A Kernan, T N Small, S L Carter, J S Thompson, G A Cloud, L S Lamb.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19617904      PMCID： PMC5445657          DOI： 10.1038/bmt.2009.170

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia.

Authors:  B N Savani; S Mielke; S Adams; M Uribe; K Rezvani; A S M Yong; J Zeilah; R Kurlander; R Srinivasan; R Childs; N Hensel; A J Barrett
Journal:  Leukemia       Date:  2007-08-02       Impact factor: 11.528

Review 2.  Immune restoration following hematopoietic stem cell transplantation: an evolving target.

Authors:  J J Auletta; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2005-05       Impact factor: 5.483

3.  Lymphocyte subset reference ranges in adult Caucasians.

Authors:  T Reichert; M DeBruyère; V Deneys; T Tötterman; P Lydyard; F Yuksel; H Chapel; D Jewell; L Van Hove; J Linden
Journal:  Clin Immunol Immunopathol       Date:  1991-08

Review 4.  Reconstitution of B cell immunity following bone marrow transplantation.

Authors:  J Storek; A Saxon
Journal:  Bone Marrow Transplant       Date:  1992-06       Impact factor: 5.483

5.  Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial.

Authors:  John E Wagner; John S Thompson; Shelly L Carter; Nancy A Kernan
Journal:  Lancet       Date:  2005 Aug 27-Sep 2       Impact factor: 79.321

6.  Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.

Authors:  U Koehl; K Bochennek; S Y Zimmermann; T Lehrnbecher; J Sörensen; R Esser; C Andreas; C Kramm; H P Grüttner; E Falkenberg; A Orth; P Bader; D Schwabe; T Klingebiel
Journal:  Bone Marrow Transplant       Date:  2007-03       Impact factor: 5.483

Review 7.  Understanding and harnessing the graft-versus-leukaemia effect.

Authors:  A John Barrett
Journal:  Br J Haematol       Date:  2008-06-28       Impact factor: 6.998

8.  Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.

Authors:  T N Small; E B Papadopoulos; F Boulad; P Black; H Castro-Malaspina; B H Childs; N Collins; A Gillio; D George; A Jakubowski; G Heller; M Fazzari; N Kernan; S MacKinnon; P Szabolcs; J W Young; R J O'Reilly
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

9.  Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.

Authors:  Nicolas Novitzky; Glenda M Davison; Geoffrey Hale; Herman Waldmann
Journal:  Transplantation       Date:  2002-12-15       Impact factor: 4.939

10.  Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.

Authors:  C A Keever; T N Small; N Flomenberg; G Heller; K Pekle; P Black; A Pecora; A Gillio; N A Kernan; R J O'Reilly
Journal:  Blood       Date:  1989-04       Impact factor: 22.113
  10 in total
  8 in total

Review 1.  Selected biological issues affecting relapse after stem cell transplantation: role of T-cell impairment, NK cells and intrinsic tumor resistance.

Authors:  Marcel van den Brink; Markus Uhrberg; Lorenz Jahn; John F DiPersio; Michael A Pulsipher
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

2.  T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies.

Authors:  Ann A Jakubowski; Trudy N Small; Nancy A Kernan; Hugo Castro-Malaspina; Nancy Collins; Guenther Koehne; Katharine C Hsu; Miguel A Perales; Genovefa Papanicolaou; Marcel R M van den Brink; Richard J O'Reilly; James W Young; Esperanza B Papadopoulos
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-11       Impact factor: 5.742

Review 3.  Novel strategies for adoptive therapy following HLA disparate transplants.

Authors:  Richard J O'Reilly; Aisha Hasan; Ekaterina Doubrovina; Guenther Koehne; Susan Prockop
Journal:  Best Pract Res Clin Haematol       Date:  2011-09       Impact factor: 3.020

4.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Authors:  Nancy Bunin; Trudy Small; Paul Szabolcs; K Scott Baker; Michael A Pulsipher; Troy Torgerson
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-17       Impact factor: 5.742

5.  Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.

Authors:  Marie Bleakley; Shelly Heimfeld; Lori A Jones; Cameron Turtle; Diane Krause; Stanley R Riddell; Warren Shlomchik
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-11       Impact factor: 5.742

6.  Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.

Authors:  Benjamin R Oshrine; Yimei Li; David T Teachey; Jennifer Heimall; David M Barrett; Nancy Bunin
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-11       Impact factor: 5.742

Review 7.  Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.

Authors:  A Saad; L S Lamb
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

Review 8.  Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy.

Authors:  Ahmed Gaballa; Lucas C M Arruda; Michael Uhlin
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.